Preclinical prevent cancer program: preclinical efficacy and intermediate endpoint biomarkers; POP: 9/22/15 - 9/21/18
Ended Awarded Last action
- Contract number
- HHSN261201500036I
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 11 $7,524,334 obligated
Award facts
- Opportunity
-
- N01CN201500036 Solicitation number
- Combined order value
- $7,524,334 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 25% used
- $29,800,000.00
- Maximum order
- $29,800,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to the University of Alabama at Birmingham (UAB) to support the agency's Preclinical Prevent Cancer Program. The program focuses on evaluating the preclinical efficacy and identifying intermediate biomarkers for potential cancer prevention agents prior to clinical trials.
Under this $29.8 million multiple-award IDC, UAB has been issued multiple firm-fixed-price delivery orders ranging from $432,272 to $1.27 million. The work involves preclinical research and development in areas such as the development of multi-antigen vaccines for bladder cancer prevention, evaluation of chemopreventive agents like 4-methylumbelliferone and STAT3 antagonists, and testing combinations of "clinically-ready" drugs like everolimus, naproxen, bazedoxifene, and lapatinib for breast and bladder cancer prevention. The contracted research is being conducted at UAB's facilities in Birmingham, Alabama, and UAB has issued subcontracts to partners like the University of Washington to support the work. This IDC does not have any set-aside designations.
Task orders
Show all 11
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN261201500036I?
HHSN261201500036I was awarded to University Of Alabama At Birmingham by National Cancer Institute (National Institutes of Health) on September 22, 2015.
How much is contract HHSN261201500036I worth?
Orders under HHSN261201500036I have obligated $7,524,334. HHSN261201500036I's own ceiling is $29,800,000. A single order can be worth up to $29,800,000.
How many orders have been placed under contract HHSN261201500036I?
11 orders have been placed under HHSN261201500036I, the latest on September 17, 2018.
Who can order from contract HHSN261201500036I?
HHSN261201500036I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN261201500036I part of a contract vehicle?
Yes. HHSN261201500036I is part of PREVENT Cancer Program (PREVENT).
Was contract HHSN261201500036I competed?
The extent of competition for HHSN261201500036I was full and open competition. The government received 9 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV